US stock futures edge lower after S&P 500 hits record high; PCE data in focus
Jared Moskowitz, the representative for Florida’s 23rd congressional district, has recently made several notable stock transactions, according to the latest Periodic Transaction (JO:TCPJ) Report.
The report indicates that Moskowitz sold stocks in Abbott Laboratories (NYSE:ABT), with each transaction valued between $1,001 and $15,000. These sales were executed on January 15, 2025, and were reported later that month. The stocks were part of the Morgan Stanley (NYSE:MS) Active Assets accounts.
In addition to Abbott Laboratories, Moskowitz also sold his holdings in the Canadian National Railway (TSX:CNR) Company (NYSE:CNI) and Merck (NSE:PROR) & Company, Inc. (NYSE:MRK). Similar to the Abbott Laboratories sales, each transaction was valued between $1,001 and $15,000.
On the other hand, Moskowitz made several purchases as well. He bought stocks in AbbVie Inc . (NYSE:ABBV), Goldman Sachs Group , Inc. (NYSE:GS), McKesson Corporation (NYSE:MCK), and Stryker Corporation (NYSE:SYK). Each of these purchases, like the sales, was valued between $1,001 and $15,000 and were also part of the Morgan Stanley Active Assets accounts.
All transactions were made from Moskowitz’s Morgan Stanley Active Assets accounts, which are based in the US. These accounts include Morgan Stanley Active Assets (1), Morgan Stanley Active Assets (5), and Morgan Stanley Active Assets (6).
The transactions were certified and signed by Moskowitz himself on February 10, 2025. As per the STOCK Act, all members of Congress are required to disclose their transactions to maintain transparency and avoid conflicts of interest.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.